Here is a breakdown of some of the important information surrounding uveal melanoma, an extremely rare form of cancer. Uveal melanoma is a rare form of eye cancer that many patients may not be aware ...
The Phase 2 OptimUM-09 trial shows promising results for uveal melanoma, addressing the lack of approved systemic therapies.
Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) is a rare paraneoplastic syndrome in which diffuse proliferation of melanocytes within the uveal tract leads to significant ocular morbidity.
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window So at AAO I gave ...
New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells ...
An expert provides insight on how primary uveal melanoma is often treated and sheds some light on an unmet need in treating the eye cancer. As recently as 20 years ago, patients with uveal melanoma ...
A University of British Columbia geneticist has discovered a gene mutation that can cause the most common eye cancer - uveal melanoma. Catherine Van Raamsdonk, an assistant professor of medical ...
-Evidence implicates ferroptosis, an emerging iron-mediated cell death, as a pathway to effectively eradicate uveal melanoma in proof-of-concept animal models -HSB-1216, a novel ferroptosis inducer ...
Servier and IDEAYA Biosciences enter into an exclusive license agreement for regulatory and commercial rights to darovasertib outside the US Darovasertib is a small molecule developed for patients ...
GENEVA--(BUSINESS WIRE)--iOnctura SA, a clinical-stage oncology company targeting key resistance mechanisms in solid tumors, announced today that it will present Phase Ib data on its lead pipeline ...
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 11 December 2024) The European Organisation for Research and Treatment of Cancer (EORTC), an independent clinical cancer research ...